Capital Analysts LLC
ASTH icon

Capital Analysts LLC’s Astrana Health ASTH Stock Holding History

Capital Analysts LLC’s Portfolio ASTH Stock Details ASTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$427 Buy
+12
New +$473 ﹤0.01% 1613

Other funds holding ASTH

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $9.18B AUM 10.37% 1-Year Est. Return
SteelPeak Wealth
SteelPeak Wealth Woodland Hills, California $4.07B AUM 38.25% 1-Year Est. Return

Capital Analysts LLC's ASTH Position: Q3 2026 in Review

Capital Analysts LLC opened a new position in Astrana Health (ASTH) in Q3 2026: 12 shares worth $427. The stake represents ﹤0.01% of the portfolio and ranks #1613 among its holdings.

173 funds tracked by Wall St. Rank hold ASTH as of Q3 2026.

  • Capital Analysts LLC held 12 shares of Astrana Health worth $427 as of Q3 2026.
  • Astrana Health was a new Capital Analysts LLC position in Q3 2026.
  • Astrana Health made up ﹤0.01% of Capital Analysts LLC's portfolio in Q3 2026, its #1613 holding.
  • 173 funds tracked by Wall St. Rank held Astrana Health as of Q3 2026.

Based on Capital Analysts LLC's 13F filing for Q3 2026, filed 13 Nov 2026.